Provided by Tiger Trade Technology Pte. Ltd.

Biohaven Pharmaceutical Holding Co Ltd.

13.65
-0.1995-1.44%
Volume:566.14K
Turnover:7.82M
Market Cap:2.05B
PE:-3.05
High:14.00
Open:13.95
Low:13.62
Close:13.85
52wk High:18.57
52wk Low:7.48
Shares:150.42M
Float Shares:117.99M
Volume Ratio:0.37
T/O Rate:0.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4800
EPS(LYR):-6.8648
ROE:-799.46%
ROA:-71.98%
PB:168.00
PE(LYR):-1.99

Loading ...

Sep 27, 2023

Major Issues Report

Form 8-K - Current report
Jul 31, 2023

Major Issues Report

Form 8-K - Current report
Jul 31, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 29, 2023

Major Issues Report

Form 8-K - Current report
May 31, 2023

Major Issues Report

Form 8-K - Current report
May 12, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 12, 2023

Major Issues Report

Form 8-K - Current report
Oct 04, 2022

Delisting

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Oct 03, 2022

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Oct 03, 2022

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Oct 03, 2022

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Oct 03, 2022

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Oct 03, 2022

Major Issues Report

8-K - Current report
Sep 29, 2022

Major Issues Report

8-K - Current report
Sep 27, 2022

Major Issues Report

8-K - Current report
Sep 23, 2022

Major Issues Report

8-K - Current report
Sep 23, 2022

Major Issues Report

8-K - Current report
Sep 19, 2022

Major Issues Report

8-K - Current report
Sep 19, 2022

Major Issues Report

8-K - Current report